日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics

优化抗体轻链框架可增强表达、生物物理特性和药代动力学

Patrice Douillard, Michael Freissmuth, Gerhard Antoine, Michael Thiele, Daniel Fleischanderl, Peter Matthiessen, Dirk Voelkel, Randolf J Kerschbaumer, Friedrich Scheiflinger, Nicolas Sabarth

Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors

国际健康捐献者群体中抗腺相关病毒免疫反应的流行情况

Anita Kruzik, Damir Fetahagic, Bettina Hartlieb, Sebastian Dorn, Herwig Koppensteiner, Frank M Horling, Friedrich Scheiflinger, Birgit M Reipert, Maurus de la Rosa

Development of Methods for the Selective Measurement of the Single Amino Acid Exchange Variant Coagulation Factor IX Padua

开发用于选择性测量单氨基酸交换变体凝血因子 IX 的方法 帕多瓦

Alfred Weber, Andrea Engelmaier, Dirk Voelkel, Robert Pachlinger, Friedrich Scheiflinger, Paul E Monahan, Hanspeter Rottensteiner

Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy

基因组编辑可扩展生产无同种抗原的慢病毒载体,用于体内基因治疗

Michela Milani, Andrea Annoni, Sara Bartolaccini, Mauro Biffi, Fabio Russo, Tiziano Di Tomaso, Andrea Raimondi, Johannes Lengler, Michael C Holmes, Friedrich Scheiflinger, Angelo Lombardo, Alessio Cantore, Luigi Naldini

Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer

氧化巨噬细胞移动抑制因子是癌症中潜在的新组织标志物和药物靶点

Alexander Schinagl, Michael Thiele, Patrice Douillard, Dirk Völkel, Lukas Kenner, Zahra Kazemi, Michael Freissmuth, Friedrich Scheiflinger, Randolf J Kerschbaumer

Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass

在需要使用心肺分流术的心脏手术后,使用不同的止血剂纠正体外凝血酶的生成

Charles L Percy, Rudolf Hartmann, Rhidian M Jones, Subramaniam Balachandran, Dheeraj Mehta, Michael Dockal, Friedrich Scheiflinger, Valerie B O'Donnell, Judith E Hall, Peter W Collins

Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura

健康个体中存在的抗 ADAMTS13 IgG 自身抗体与血栓性血小板减少性紫癜患者的抗体具有相同的线性表位

Rana Grillberger, Veronica C Casina, Peter L Turecek, X Long Zheng, Hanspeter Rottensteiner, Friedrich Scheiflinger

Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI)

小肽阻断组织因子途径抑制剂 (TFPI) 对因子 Xa 和组织因子 - 因子 VIIa 的抑制

Michael Dockal, Rudolf Hartmann, Markus Fries, M Christella L G D Thomassen, Alexandra Heinzmann, Hartmut Ehrlich, Jan Rosing, Frank Osterkamp, Thomas Polakowski, Ulrich Reineke, Andreas Griessner, Hans Brandstetter, Friedrich Scheiflinger

Neutralization of macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the β-sheet structure of MIF

全人抗体对巨噬细胞移动抑制因子 (MIF) 的中和作用与其对 MIF β 片层结构的特异性相关

Randolf J Kerschbaumer, Manfred Rieger, Dirk Völkel, Didier Le Roy, Thierry Roger, Jurate Garbaraviciene, Wolf-Henning Boehncke, Jürgen Müllberg, Rene M Hoet, Clive R Wood, Gerhard Antoine, Michael Thiele, Helga Savidis-Dacho, Michael Dockal, Hartmut Ehrlich, Thierry Calandra, Friedrich Scheiflinger

Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy

造血祖细胞介导的基因治疗纠正小鼠 ADAMTS13 缺陷

Pablo Laje, Dezhi Shang, Wenjing Cao, Masami Niiya, Masayuki Endo, Antoneta Radu, Nicole DeRogatis, Friedrich Scheiflinger, Philip W Zoltick, Alan W Flake, X Long Zheng